1. Home
  2. Medical Devices
  3. Nasal Drug Delivery Technology Market - By Dosage Form (Spra...
Category : Medical Devices
Envisage report cover

Nasal Drug Delivery Technology Market - By Dosage Form (Sprays, Drops & Liquids, Powders, Gels), By Therapeutic Application (Allergic and Non-allergic Rhinitis, Nose Congestion, Vaccination, Other), By End User (Home Care Settings, Hospitals) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 203

Status: Published

Report Code: ARI100702

The Global Nasal Drug Delivery Technology Market is projected to reach USD 69.73 billion by 2027 from USD 49.69 billion in 2020, at a CAGR of 6.5 % during the forecast period. Nasal drug delivery technology is the administration of drug through the nasal route. Nasal route of administration provides direct access to the systemic circulation. The nasal cavity is an easily accessible route which is generally well tolerated. Drugs administered through the nasal route are available in different dosage forms, such as liquid drops, liquid spray, Aerosol, suspension spray, gel etc. Nasal drug delivery offers several advantages, such as a large surface area for drug absorption, convenience, and good patient compliance, rapid attainment of therapeutic drug levels in the blood, and potential of direct drug delivery to the brain along the olfactory nerves etc. In nasal drug delivery, drugs are given in multi dose as well as single dose. Intranasal medication administration offers a needleless solution to drug delivery. Many drugs have been shown to achieve better systemic bioavailability through the nasal route than by oral administration. Different formulations are delivered through the nasal route, such as drugs, viscosifying agents, solubilizes, surfactants, bio adhesive polymers, preservatives etc.

Factors such as growing preference for nasal drug delivery, technological advancement, growing adoption for self-administration, and growing incidence of chronic diseases are likely to drive the global nasal drug delivery technology market. New product innovation, large pipeline products, and merger & acquisition activities are other factors which will accelerate the nasal drug delivery technology market globally. On the other hand, complications related to nasal drug delivery, such as risk of local side effects and low bioavailability are factors which may hinder the growth of the nasal drug delivery technology market.

Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. This can majorly be attributed to the non-invasive nature of this route of delivery and the fact that drug absorbability is higher through the nasal route. In addition, the nasal route offers a less hostile environment as compared to the gastro-intestinal route; this enables better absorption of drugs. Moreover, nasal drug delivery, unlike some other routes of drug delivery, does not require any sterile method for administering drugs into the body. The easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which in turn drives patient outcomes. Considering these factors, the preference for nasal drug delivery is increasing among patients as well as healthcare providers.

Major players operating in this market include Becton, Dickinson and Company, OptiNose US Inc., Bespak Europe Ltd, Kurve Technology, Inc., AstraZeneca Plc, Teleflex Medical Europe Ltd., AptarGroup, Inc., Procter & Gamble, GlaxoSmithKline plc, and Janssen Global Services, LLC.

Analyst Commentary

Based on container type, non-pressurized was the largest container type segment . These containers are usually found in nasal drops, powders, and gels. Growing demand for related products is expected to propel the segment over the forecast period. Furthermore, according to an article published by Intertek Group PLC, nasal drug delivery technologies enable systematically or topical drug delivery.

The nasal drug delivery technology market in Asia is expected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities.

Segmentation

The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user and region. On the basis of system, the market is segmented into multi-dose systems, bi-dose systems, and unit-dose systems. Based on container type, the nasal drug delivery systems market is segmented into pressurized and non-pressurized containers. Based on application the market is bifurcated into Allergic and Non-allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications. Based on dosage the market is segmented into Sprays, Drops & Liquids, Powders, Gels.

Regional Analysis

Geographically, the market has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to dominate the global nasal drug delivery market owing to an increasing prevalence of rhinitis, congestion, sinusitis, and respiratory allergic reactions.

Additionally, the well-developed healthcare sector and presence of a large number of medical device companies in this region boosts the market growth. According to the Centers for Disease Control and Prevention January 2017, 30.8 million adults were diagnosed with sinusitis in the US.

Europe is expected to hold the second-largest position in the global nasal drug delivery market. The presence of a large patient population suffering from chronic disorders, increasing technological advancement in the healthcare industry, and growing mergers and acquisitions between healthcare companies drives the market growth in this region.

Alabama Nasal Drug Delivery Association (ADMEA) is a Europe based non-profit organization involved in providing home medical equipment. The presence of such organization in Europe enhances the market growth during the forecasted period.

Asia-Pacific is expected to be fastest-growing region owing to the growing geriatric population and increasing incidences of allergy diseases, which is a common cause of respiratory problems in developing countries.

The Middle East & Africa holds the least share of the market. A majority of the market share of this region is expected to be held by the Middle East due to growing government initiatives for the healthcare sector in this region.

"

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Dosage Form
2.3.1. Secondary Dosage Form
2.3.1.1. Preliminary data mining
2.3.2. Primary Dosage Form
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Nasal Drug Delivery Technology Market
Chapter 5. Global Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
5.1. Global Nasal Drug Delivery Technology Market Share, By Dosage Form, 2015 - 2027 (USD Million)
5.1.1. Sprays
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Drops and Liquids
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Powders
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Others
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
6.1. Global Nasal Drug Delivery Therapeutic Application Share, By Therapeutic Application, 2015 - 2027 (USD Million)
6.1.1. Allergic and Non-allergic Rhinitis
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Nose Congestion
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Vaccination
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Others
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
7.1. Global Nasal Drug Delivery Therapeutic Application Share, By End-Users, 2015 - 2027 (USD Million)
7.1.1. Home Care Settings
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Hospitals
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Nasal Drug Delivery Technology Market Overview, By Geography, 2015 – 2027 (USD Million)
8.1. Global Nasal Drug Delivery Technology Market Share, By Geography, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 9. Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. Powders Global Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
9.1.2. Global Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
9.1.3. Global Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
9.1.4. Global Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.5. Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
9.1.5.1.4. U.S. Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.5.2. Canada Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
9.1.5.2.4. Canada Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.5.3. Mexico Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
9.1.5.3.4. Mexico Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 10. Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Global Nasal Drug Delivery Technology Market Overview, 2015 – 2027 (USD Million)
10.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.2. Global Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.3. Global Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.4. Global Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5. Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.1.3. Germany Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.1.4. Germany Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5.2. France
10.1.5.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.2.3. France Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.2.4. France Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5.3. UK
10.1.5.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.3.3. UK Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.3.4. UK Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5.4. Italy
10.1.5.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.4.3. Italy Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.4.4. Italy Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5.5. Spain
10.1.5.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.5.3. Spain Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.5.4. Spain Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.5.6. Rest of Drops and Liquids
10.1.5.6.1. Market size and projections, 2015 – 2025
10.1.5.6.2. Rest of Global Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
10.1.5.6.3. Rest of Global Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
10.1.5.6.4. Rest of Global Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 11. Asia Pacific Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.5. Asia Pacific Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.5.1.3. India Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.5.1.4. India Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.5.2. China
11.1.5.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.5.2.2. China Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.5.2.3. China Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.5.2.4. China Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.5.3. Japan
11.1.5.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.5.3.3. Japan Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.5.3.4. Japan Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.5.4. South Korea
11.1.5.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.5.4.2. South Korea Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.5.4.3. South Korea Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.5.4.4. South Korea Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
11.1.5.5.3. Rest of Asia Pacific Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
11.1.5.5.4. Rest of Asia Pacific Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 12. Middle East & Africa Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
12.1.5.1.4. GCC Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.5.2. South Africa
12.1.5.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
12.1.5.2.4. South Africa Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
12.1.5.3.4. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 13. South America Global Nasal Drug Delivery Technology Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Nasal Drug Delivery Technology Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
13.1.2. South America Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
13.1.3. South America Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
13.1.4. South America Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
13.1.5. South America Nasal Drug Delivery Technology Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.5.1. Brazil
13.1.5.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
13.1.5.1.2. Brazil Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
13.1.5.1.3. Brazil Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
13.1.5.1.4. Brazil Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
13.1.5.2. Argentina
13.1.5.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
13.1.5.2.2. Argentina Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
13.1.5.2.3. Argentina Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
13.1.5.2.4. Argentina Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
13.1.5.3. Rest of South America
13.1.5.3.1. Market size and projections, 2015 – 2026
13.1.5.3.2. Rest of South America Nasal Drug Delivery Technology Market Overview, By Dosage Form, 2015 - 2027 (USD Million)
13.1.5.3.3. Rest of South America Nasal Drug Delivery Technology Market Overview, By Therapeutic Application, 2015 - 2027 (USD Million)
13.1.5.3.4. Rest of South America Nasal Drug Delivery Technology Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Dosage Form & Sprays
Chapter 15. Key Player Analysis
15.1. Becton
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Dosage Form & Sprays Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Dickinson and Company
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Dosage Form & Sprays Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. OptiNose US Inc
15.4. Bespak Europe Ltd
15.5. Kurve Technology, Inc
15.6. AstraZeneca Plc,
15.7. Teleflex Medical Europe Ltd.
15.8. AptarGroup, Inc.
15.9. Procter & Gamble
15.10. GlaxoSmithKline plc
Chapter 16. Global Nasal Drug Delivery Technology Market Cost Analysis
16.1. Global Nasal Drug Delivery Technology Market Key Raw Dosage Form Analysis
16.1.1. Key Raw Dosage Form
16.1.2. Trend of Key Raw Dosage Form
16.1.3. Key Suppliers of Raw Dosage Form
16.1.4. Market Concentration Rate of Raw Dosage Form
16.2. Proportion of Wing Cost Structure
16.2.1. Raw Dosage Form
16.2.2. Labor Cost
16.2.3. Wing Expenses
16.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 17. Chain, Sourcing Strategy and Downstream Buyers
17.1. Global Nasal Drug Delivery Technology Market Chain Analysis
17.2. Upstream Raw Dosage Form Sourcing
17.3. Raw Dosage Form of Global Nasal Drug Delivery Technology Market Major Manufacturers in 2019
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Home Care Settings Damage
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Dosage Form & Sprays Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Dosage Form & Sprays Progress in Related Dosage Form
19.2. Sprays Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Nasal Drug Delivery Technology Market share, by Dosage Form, 2020 & 2027 (%)
10. Global Nasal Drug Delivery Technology Market share, by Sprays, by Dosage Form, 2020 & 2027 (USD Million)
11. Global Nasal Drug Delivery Technology Market share, by Drops and Liquids, by Dosage Form, 2020 & 2027 (USD Million)
12. Global Nasal Drug Delivery Technology Market share, by Powders, by Dosage Form, 2020 & 2027 (USD Million)
13. Global Nasal Drug Delivery Technology Market share, by Therapeutic Application, 2020 & 2027 (%)
14. Global Nasal Drug Delivery Technology Market share, by Allergic and Non-allergic Rhinitis Acid, by Dosage Form, 2020 & 2027 (USD Million)
15. Global Nasal Drug Delivery Technology Market share, by Nose Congestion, by Therapeutic Application, 2020 & 2027 (USD Million)
16. Global Nasal Drug Delivery Technology Market share, by Vaccination, by Therapeutic Application, 2020 & 2027 (USD Million)
17. Global Nasal Drug Delivery Technology Market share, by End-Users, 2020 & 2027 (%)
18. Global Nasal Drug Delivery Technology Market share, by Home Care Settings, by End-Users, 2020 & 2027 (USD Million)
19. Global Nasal Drug Delivery Technology Market share, by Hospitals, by End-Users, 2020 & 2027 (USD Million)
20. Global Nasal Drug Delivery Technology Market share, by region, 2020 - 2027(%)
21. Global Nasal Drug Delivery Technology Market share, by region, 2019 - 2027(USD Million)
22. Powders Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
23. Powders Global Nasal Drug Delivery Technology Market share, by Countries, 2020 & 2027 (%)
24. U.S. Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
25. Canada Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
26. Drops and Liquids Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
27. Drops and Liquids Global Nasal Drug Delivery Technology Market share, by Countries, 2020 & 2027 (%)
28. Spain Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
29. UK Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
30. Italy Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
31. Germany Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
32. France Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
33. Rest of Drops and Liquids Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
34. Asia-Pacific Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
35. Asia-Pacific Global Nasal Drug Delivery Technology Market share, by Countries, 2020 & 2027 (%)
36. China Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
37. India Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
38. Australia Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
39. Japan Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
40. Rest of Asia-Pacific Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
41. Middle East & Africa Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
42. Middle East & Africa Global Nasal Drug Delivery Technology Market share, by Countries, 2020 & 2027 (%)
43. GCC Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
44. South Africa Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
45. Rest of Middle East & Africa Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
46. South America Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
47. Brazil Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
48. Mexico Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
49. Argentina Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)
50. Rest Of South America Global Nasal Drug Delivery Technology Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Nasal Drug Delivery Technology Market, 2020-2027 (USD Million)
4. Nasal Drug Delivery Therapeutic Application requirement, by country, 2020-2027, (USD Million)
5. Global Nasal Drug Delivery Technology Market, By Dosage Form, 2020-2027 (USD Million)
6. Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2027 (USD Million)
7. Global Nasal Drug Delivery Technology Market, by End-Users, 2020-2027 (USD Million)
8. Global Nasal Drug Delivery Technology Market, By Dosage Form, 2020-2027 (USD Million)
9. Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2027 (USD Million)
10. Global Nasal Drug Delivery Technology Market, by End-Users, 2020-2027 (USD Million)
11. Asia Pacific Nasal Drug Delivery Technology Market, By Dosage Form, 2020-2027 (USD Million)
12. Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2027 (USD Million)
13. Asia Pacific Nasal Drug Delivery Technology Market, by End-Users, 2020-2027 (USD Million)
14. Middle East & Africa Global Nasal Drug Delivery Technology Market, By Dosage Form, 2020-2027 (USD Million)
15. Middle East & Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2027 (USD Million)
16. Middle East & Africa Nasal Drug Delivery Technology Market, by End-Users, 2020-2027 (USD Million)
17. South America Nasal Drug Delivery Technology Market, By Dosage Form, 2020-2027 (USD Million)
18. South America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2027 (USD Million)
19. South America Nasal Drug Delivery Technology Market, by End-Users, 2020-2027 (USD Million)
20. Global Nasal Drug Delivery Technology Market, Company Market Share, 2018 (%)
21. Becton: Product Benchmarking
22. Becton: Financial Performance
23. Dickinson and Company, Product Benchmarking
24. Dickinson and Company, Financial Performance
25. OptiNose US Inc : Product Benchmarking
26. OptiNose US Inc : Financial Performance
27. Bespak Europe Ltd: Product Benchmarking
28. Bespak Europe Ltd: Financial Performance
29. Kurve Technology, Inc : Product Benchmarking
30. Kurve Technology, Inc : Financial Performance
31. AstraZeneca Plc,: Product Benchmarking
32. AstraZeneca Plc,: Financial Performance
33. Teleflex Medical Europe Ltd.: Product Benchmarking
34. Teleflex Medical Europe Ltd.: Financial Performance
35. AptarGroup, Inc.: Product Benchmarking
36. AptarGroup, Inc.: Financial Performance
37. Procter & Gamble: Product Benchmarking
38. Procter & Gamble: Financial Performance
39. GlaxoSmithKline plc: Product Benchmarking
40. GlaxoSmithKline plc: Financial Performance

The Leading Key Players in Nasal Drug Delivery Technology Market

Becton
Dickinson and Company
OptiNose US Inc.
Bespak Europe Ltd
Kurve Technology Inc.
AstraZeneca Plc
Teleflex Medical Europe Ltd.
AptarGroup Inc.
Procter & Gamble
GlaxoSmithKline plc
Janssen Global Services
LLC.

Sample Request Form